[The etiology and pathogenesis of dilated cardiomyopathy]

Vrachebnoe Delo
|November 1, 1989
PubMed

Insights

Dilated cardiomyopathy may stem from a systemic immune issue, as indicated by connective tissue changes and immune complexes in skin biopsies. These findings were less common in hypertrophic cardiomyopathy patients.

Area of Science:

  • Cardiology
  • Immunology
  • Pathology

Background:

  • Cardiomyopathies are heart muscle diseases of unknown origin.
  • Dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM) are distinct forms.
  • Systemic involvement in cardiomyopathies is not fully understood.

Purpose of the Study:

  • To investigate the potential systemic origins of cardiomyopathies.
  • To examine skin biopsies for signs of systemic disease in DCM and HCM patients.
  • To correlate findings with circulating immune complex levels.

Main Methods:

  • Analysis of skin biopsies from patients with DCM and HCM.
  • Morphological examination of connective tissue in skin biopsies.
  • Measurement of circulating immune complexes in patient blood samples.

Main Results:

  • DCM patients frequently exhibited morphological signs of systemic connective tissue disease.
  • Elevated levels of circulating immune complexes were observed in DCM patients.
  • Similar systemic changes were found in only one HCM patient, suggesting a difference in etiology.

Conclusions:

  • Dilated cardiomyopathy is often a manifestation of a systemic immunopathological process.
  • Skin biopsy findings suggest a broader connective tissue involvement in DCM.
  • The etiology of HCM may differ significantly from DCM, with less evidence of systemic immune involvement.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...